Prostate Cancer - Results from #23640

A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1968 to 2006 - Abstract July 27, 2012

PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report - Abstract July 26, 2012

Emerging targeted therapies for castration-resistant prostate cancer - Abstract July 26, 2012

Focal therapy, differential therapy, and radiation treatment for prostate cancer - Abstract July 26, 2012

Analysis of survival in radical and postoperative radiotherapy for prostate cancer - Abstract July 26, 2012

Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer - Abstract July 26, 2012

High-grade prostatic intraepithelial neoplasia - Abstract July 26, 2012

Focal laser ablation of prostate cancer: Definition, needs, and future - Abstract July 26, 2012

Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression - Abstract July 26, 2012

Obesity and prostate cancer : Role of adipocytokines and clinical implications - Abstract July 26, 2012

Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study - Abstract July 26, 2012

Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI - Abstract July 25, 2012

Prostate cancer - A biomarker perspective - Abstract July 25, 2012

Toward maximizing immunotherapy in metastatic castration-resistant prostate cancer - Rationale for combinatorial approaches using chemotherapy - Abstract July 25, 2012

Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients - Abstract July 25, 2012

Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate - Abstract July 25, 2012

Prostate cancer screening: Attitudes and practices of family physicians in Ontario - Abstract July 25, 2012

Prostate Cancer Localization using Multiparametric MRI based on Semi-supervised Techniques with Automated Seed Initialization - Abstract July 25, 2012

Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate - Abstract July 25, 2012

Successful treatment of advanced metastatic prostate cancer following chemotherapy based on molecular profiling - Abstract July 25, 2012

Page 1183 of 1351